financetom
Business
financetom
/
Business
/
Eversource flags $520 mln loss in Q3, lower proceeds from offshore wind sale
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Eversource flags $520 mln loss in Q3, lower proceeds from offshore wind sale
Oct 2, 2024 9:51 PM

Sept 30 (Reuters) - Eversource Energy ( ES ) expects to

incur an aggregate net loss on the completion of its offshore

wind business divesture of $520 million in the third quarter,

the U.S. utility firm said on Monday.

The forecasted net loss includes a liability of $360

million, majority of which is expected to be settled in 2026,

the company said in a statement.

The utility added it has only realized $745 million in

adjusted gross proceeds from the sale of its South Fork Wind and

Revolution Wind projects to Global Infrastructure Partners,

compared to the expected purchase price of $1.12 billion.

Lower proceeds from the sale, Eversource said, reflect lower

capital spending between February and September, and delay of

the commercial operations date of the Revolution Wind project.

However, CFO John Moreira said that "(the offshore wind

business divestiture) is not expected to have a material impact

to our targeted funds from operations/Debt ratio of 14% to 15%

by 2025."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: DexCom Shares Rise After Prescription-Free Glucose Biosensor Wins FDA Clearance
Update: DexCom Shares Rise After Prescription-Free Glucose Biosensor Wins FDA Clearance
Mar 6, 2024
01:18 PM EST, 03/06/2024 (MT Newswires) -- (Updates with the latest stock movement in the headline and first paragraph.) DexCom's ( DXCM ) shares were up more than 9% in recent Wednesday trading after the company's prescription-free glucose biosensor, Stelo by Dexcom ( DXCM ), won clearance from the US Food and Drug Administration on Tuesday. Stelo, designed for individuals...
Spanish Healthcare Firm Grifols Hit With New Gotham City's Short Report, Faces Questions Regarding Transparency, Integrity, Ethical Conduct
Spanish Healthcare Firm Grifols Hit With New Gotham City's Short Report, Faces Questions Regarding Transparency, Integrity, Ethical Conduct
Mar 6, 2024
Grifols ( GRFS ) SA shares are down on Wednesday following the publication of a new report by Gotham City Research questioning the company’s “transparency, integrity and ethical conduct.” Grifols ( GRFS ) had previously denied Gotham City’s accusations, as per its February SEC filing, saying it had already replied to all of the questions raised in the latter’s reports. Grifols ( GRFS ) claimed...
Update: Albemarle Rises After Pricing of Upsized Offering of Depositary Shares
Update: Albemarle Rises After Pricing of Upsized Offering of Depositary Shares
Mar 6, 2024
01:21 PM EST, 03/06/2024 (MT Newswires) -- (Updates to add stock move in the headline and the first paragraph.) Albemarle (ALB) shares rose more than 8% in recent Wednesday trading after the company priced its underwritten public offering of 40 million depositary shares at $50 apiece, upsized from $1.75 billion previously. Each depositary share represents a 1/20th interest in a...
Update: Brown-Forman Shares Fall After Surprise Dip in Fiscal Q3 Sales
Update: Brown-Forman Shares Fall After Surprise Dip in Fiscal Q3 Sales
Mar 6, 2024
01:22 PM EST, 03/06/2024 (MT Newswires) -- (Updates with recent stock move in the headline and first paragraph.) Brown-Forman (BF.A, BF.B) shares fell 9% in recent Wednesday trading as the company's fiscal Q3 sales dipped unexpectedly. Earlier in the day, the company reported fiscal Q3 earnings of $0.60 per diluted share, up from $0.21 a year earlier. Analysts polled by...
Copyright 2023-2026 - www.financetom.com All Rights Reserved